The published data suggest that the combined effects of the PI3K/mTOR and MEK pathways may be important for cancer growth, pointing to the possibility that combined blockage of these two signaling pathways may be an important component of successful breast cancer treatment strategies. This evidence concerns the gene PIK3CA and breast cancer.